Marmara Uni Faculty of Medicine

Istanbul 34890

0 studies enrolling now · 2 studies all time

What they study most

Breast Cancer, Solid Tumors

Studies at this site

• A Study Evaluating the Efficacy and Safety of Inavolisib Plus Fulvestrant Compared With Alpelisib Plus Fulvestrant in Participants With HR-Positive, HER2-Negative, PIK3CA Mutated, Locally Advanced or Metastatic Breast Cancer Post CDK4/6i and Endocrine Combination Therapy — Running, not enrolling
• Screening Study for Participants With Malignant Tumors — Completed